Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Anika Therapeutics (ANIK) Assets Average: 2011-2024

Historic Assets Average for Anika Therapeutics (ANIK) over the last 14 years, with Dec 2024 value amounting to $236.7 million.

  • Anika Therapeutics' Assets Average fell 23.67% to $188.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $188.6 million, marking a year-over-year decrease of 23.67%. This contributed to the annual value of $236.7 million for FY2024, which is 23.62% down from last year.
  • Latest data reveals that Anika Therapeutics reported Assets Average of $236.7 million as of FY2024, which was down 23.62% from $309.9 million recorded in FY2023.
  • In the past 5 years, Anika Therapeutics' Assets Average ranged from a high of $356.6 million in FY2021 and a low of $236.7 million during FY2024.
  • In the last 3 years, Anika Therapeutics' Assets Average had a median value of $309.9 million in 2023 and averaged $298.3 million.
  • Per our database at Business Quant, Anika Therapeutics' Assets Average grew by 14.21% in 2020 and then declined by 23.62% in 2024.
  • Anika Therapeutics' Assets Average (Yearly) stood at $348.2 million in 2020, then grew by 2.42% to $356.6 million in 2021, then dropped by 2.31% to $348.3 million in 2022, then decreased by 11.04% to $309.9 million in 2023, then declined by 23.62% to $236.7 million in 2024.